3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
47
Neoplasms
21
Breast Neoplasms
19
Triple Negative Breast Neoplasms
16
Melanoma
15
Urinary Bladder Neoplasms
14
Carcinoma, Transitional Cell
14
Carcinoma, Hepatocellular
13
Small Cell Lung Carcinoma
11
Ovarian Neoplasms
11
Neoplasm Metastasis
11
Colorectal Neoplasms
11
Uterine Cervical Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
8
Solid Tumors
6
Head and Neck Neoplasms
6
Carcinoma, Renal Cell
6
Lymphoma
5
Esophageal Neoplasms
5
Stomach Neoplasms
4
Lung Neoplasms
4
Kidney Neoplasms
4
Sarcoma
3
Pancreatic Neoplasms
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Endometrial Neoplasms
3
Biliary Tract Neoplasms
3
Urologic Neoplasms
2
Solid Tumor
2
Interventions
pembrolizumab
125
Cisplatin
28
Carboplatin
25
lenvatinib
24
Paclitaxel
20
Docetaxel
16
Fluorouracil
13
Pemetrexed
11
Capecitabine
11
Gemcitabine
10
Saline Solution
8
Oxaliplatin
8
epacadostat
6
Leucovorin
5
Irinotecan
5
Cetuximab
5
Albumin-Bound Paclitaxel
5
130-nm albumin-bound paclitaxel
5
olaparib
4
Bevacizumab
4
trifluridine tipiracil drug combination
3
regorafenib
3
enzalutamide
3
durvalumab
3
Nivolumab
3
Etoposide
3
trametinib
2
etoposide phosphate
2
dabrafenib
2
Tretinoin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
atezolizumab
×
Clear all
NCT07192926
2026-02-20
SARCO-CTI
Ankara Etlik City Hospital
Completed
131 enrolled